IGC Pharma (IGC) Earnings Date, Estimates & Call Transcripts → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free IGC Stock Alerts $0.44 -0.02 (-4.73%) (As of 03:27 PM ET) Add Compare Share Share EarningsStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsShort Interest Earnings SummaryLatest Earnings DateFeb. 14EstimatedActual EPS (Feb. 14) -$0.09 Missed By -$0.09 Get IGC Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for IGC and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueIGC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.IGC Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… IGC Earnings Date and InformationIGC Pharma last released its quarterly earnings results on February 14th, 2024. The construction company reported ($0.09) earnings per share (EPS) for the quarter. The business earned $0.20 million during the quarter. IGC Pharma has generated ($0.26) earnings per share over the last year (($0.26) diluted earnings per share). Read More IGC Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/14/2024Q3 2024-($0.09)($0.09)($0.09)-$0.20 million11/9/2023Q2 2024-($0.05)($0.05)($0.05)-$0.29 million8/10/2023Q1 2024-($0.04)($0.04)($0.04)-$0.56 million7/7/2023Q4 2023-($0.08)($0.08)($0.08)-$0.17 million2/14/2023Q3 2023-($0.04)($0.04)($0.04)-$0.33 million11/1/2022Q2 2023-($0.05)($0.05)($0.05)-$0.20 million Get the Latest News and Ratings for IGC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IGC Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q1 2023-($0.05)($0.05)($0.05)-$0.21 million6/22/2022Q4 2022-($0.13)($0.13)($0.13)-$0.12 million2/10/2022Q3 2022-($0.05)($0.05)($0.05)-$0.14 million10/29/2021Q2 2022-($0.09)($0.09)($0.09)-$0.06 million8/11/2021Q1 2022-($0.04)($0.04)($0.04)-$0.08 million6/14/2021Q4 2021-($0.07)($0.07)($0.07)-$0.08 million IGC Pharma Earnings - Frequently Asked Questions When did IGC Pharma announce their last quarterly earnings? IGC Pharma (NYSEAMERICAN:IGC) last announced its quarterly earning data on Wednesday, February 14, 2024. Learn more on IGC's earnings history. How much revenue does IGC Pharma generate each year? IGC Pharma (NYSEAMERICAN:IGC) has a recorded annual revenue of $910,000.00. How much profit does IGC Pharma generate each year? IGC Pharma (NYSEAMERICAN:IGC) has a recorded net income of -$11.51 million. IGC has generated -$0.26 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Theratechnologies Earnings Results Aprea Therapeutics Earnings Results IntelGenx Technologies Earnings Results CASI Pharmaceuticals Earnings Results Helix BioPharma Earnings Results Lexaria Bioscience Earnings Results JanOne Earnings Results Spruce Biosciences Earnings Results Fortress Biotech Earnings Results Viracta Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSEAMERICAN:IGC) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Startop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
